Gemcitabine P lus V inorelbine V ersus V inorelbine A lone i n Elderly P atients W ith A dvanced N on-Small-Cell Lung C ancer
G. Frasci(Radiation Oncology Institute), Mario De Lena(Radiation Oncology Institute), Annunziato Iannelli(Radiation Oncology Institute), Francovito Piantedosi(Ospedale Monaldi), Domenico Bilancia(Azienda Ospedaliera Ospedale San Carlo Borromeo), B. Massidda(Policlinico Universitario di Catania), Andrea Bianco(Keele University), Vito Lorusso, Pasquale Comella(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), M Belli(Radiation Oncology Institute), Giuseppe Comella(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Nicola Panza(Radiation Oncology Institute), G.P. Nicolella(Radiation Oncology Institute)
Unknown
January 1, 2000
Cited by 0
Related Papers
Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2000|452
Polymorphism at the Glutathione <i>S</i> -transferase GSTP1 Locus: A New Marker for Bronchial Hyperresponsiveness and Asthma
|American Journal of Respiratory and Critical Care Medicine|2000|263
Randomized Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine With Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer: Interim Analysis of a Phase III Trial of the Southern Italy Cooperative Oncology Group
|Journal of Clinical Oncology|2000|177
Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
|Lung Cancer|2019|158
Adiponectin as Link Factor between Adipose Tissue and Cancer
|International Journal of Molecular Sciences|2019|138